文献速递生殖医学

长期米托坦治疗肾上腺皮质癌所致特异性卵巢功能不全患者经未成熟卵母细胞体外成熟后获得活产

Live birth after in-vitro maturation of oocytes in a patient with specific ovarian insufficiency caused by long-term mitotane treatment for adrenocortical carcinoma.
PubMed 文献 · Reprod Biomed Online · 2021-10-17

一例33岁肾上腺皮质癌术后长期接受米托坦治疗的女性因不孕转诊,停药5年后仍持续闭经且卵巢功能特异性地受损。在促排卵失败后,采用未刺激取卵行未成熟卵母细胞体外成熟(IVM)及显微注射,最终在激素替代治疗(HRT)周期中移植单枚第2天胚胎后获得健康活产。

要点

  • 长期米托坦暴露可导致停药后持续5年的特异性卵巢功能不全。
  • 该患者促排卵失败后,采用未刺激取卵行IVM获得7枚成熟卵母细胞。
  • HRT周期中移植单枚第2天胚胎后获得健康活产,为该情形下首例IVM后活产。

核心结论

  • 报告了停用米托坦5年后仍存在持续性特异性卵巢功能受损,以及该情形下首例经IVM获得的活产。
  • 作者提出长期米托坦治疗前生育力保存的问题。

研究设计与样本

  • 病例报告。
  • 患者为33岁女性,因肾上腺皮质癌接受手术并接受米托坦治疗,因不孕转诊。

主要发现

  • 服用米托坦期间迅速闭经,停药后持续5年。
  • 反复血清激素评估显示雄激素水平崩溃、雌二醇低、促性腺激素高(LH 69和63;FSH 23和43 IU/l)、抑制素B相对较高、抗苗勒管激素轻度降低(1.4和0.7 ng/ml)。
  • 超声显示窦卵泡计数为13,与高血清促性腺激素水平形成反差。
  • 卵巢刺激后未能获得卵泡生长,遂从窦卵泡抽吸未成熟卵母细胞行IVM并与配偶精子显微注射。
  • 进行了两个周期未刺激取卵,获得7枚IVM卵母细胞并显微注射,共3枚卵裂期胚胎玻璃化冷冻,HRT子宫内膜准备后移植未成功;间隔20个月后,在HRT下进行两次新鲜胚胎移植尝试,最后一次移植单枚第2天胚胎后成功,患者分娩一健康婴儿。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: How should the fertility of a woman with persistent specific ovarian dysfunction after long-term mitotane exposure be managed? DESIGN: Case report. A 33-year-old woman who underwent surgery for adrenocortical carcinoma and treated with mitotane was referred for infertility. She rapidly became amenorrhoeic while taking mitotane, a condition that persisted for 5 years after cessation. Repeated serum hormone evaluation showed collapsed androgen levels, low oestradiol, high gonadotrophins (LH 69 and 63; FSH 23 and 43 IU/l), relatively high inhibin B level and slightly decreased anti-Müllerian hormone levels (1.4 and 0.7 ng/ml). An ultrasound scan revealed an antral follicle count of 13, contrasting with high serum gonadotrophin levels. After failure to obtain follicular growth after ovarian stimulation, in-vitro maturation (IVM) of immature oocytes aspirated from the antral follicles was carried out for microinjection with the spermatozoa of the patient's partner. RESULTS: Two cycles of unstimulated egg retrieval were carried out, producing seven IVM oocytes, which were microinjected. A total of three cleavage-stage embryos were vitrified and unsuccessfully transferred after endometrial preparation using hormone replacement therapy (HRT). After a 20-month break, two new attempts were carried out under HRT with the aim of achieving a fresh embryo transfer. The last attempt succeeded after transfer of a single day-2 embryo, and the patient delivered a healthy baby. CONCLUSION: Persistent specific impaired ovarian function 5 years after withdrawal of mitotane, and the first live birth after IVM in this situation, are reported. The question of fertility preservation before long-term mitotane treatment is raised.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Bry-Gauillard H, Belin F, Vinolas C, et al. Live birth after in-vitro maturation of oocytes in a patient with specific ovarian insufficiency caused by long-term mitotane treatment for adrenocortical carcinoma. Reprod Biomed Online. 2021. PMID: 34815159. doi:10.1016/j.rbmo.2021.10.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。